 BOSTON, Jan. 06, 2021 GLOBE NEWSWIRE -- Yumanity Therapeutics Nasdaq: YMTX, a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced that Paulash Mohsen, Chief Business Officer, will present at the H.C. Wainwright Virtual BioConnect Conference. 